BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3147080)

  • 1. Fatal ischaemic brain oedema after early thrombolysis with tissue plasminogen activator in acute stroke.
    Koudstaal PJ; Stibbe J; Vermeulen M
    BMJ; 1988 Dec; 297(6663):1571-4. PubMed ID: 3147080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous thrombolysis for acute ischaemic stroke: preliminary experience with recombinant tissue plasminogen activator in the UK.
    Walters MR; Muir KW; Harbison J; Lees KR; Ford GA
    Cerebrovasc Dis; 2005; 20(6):438-42. PubMed ID: 16230848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intravenous thrombolytic therapy: ideal treatment for acute ischemic stroke].
    Kappelle LJ; van der Worp HB
    Ned Tijdschr Geneeskd; 2000 May; 144(22):1025-8. PubMed ID: 10850102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke.
    Millan M; Sobrino T; Castellanos M; Nombela F; Arenillas JF; Riva E; Cristobo I; García MM; Vivancos J; Serena J; Moro MA; Castillo J; Dávalos A
    Stroke; 2007 Jan; 38(1):90-5. PubMed ID: 17138950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood-brain barrier pathophysiology and ischaemic brain oedema].
    Gasche Y; Copin JC
    Ann Fr Anesth Reanim; 2003 Apr; 22(4):312-9. PubMed ID: 12818323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombolytic treatment of acute cerebral infarction].
    Boysen G; Vorstrup S; Meden P; Ballegaard M; Soyka S; Højgaard J; Voldsgaard A; Grønbech-Jensen M; Løwbech Y; Karle A; Friberg L
    Ugeskr Laeger; 2001 Aug; 163(35):4741-4. PubMed ID: 11572049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with tPA predicts better outcome even if MCA occlusion persists.
    Kablau M; Alonso A; Hennerici MG; Fatar M
    Int J Stroke; 2013 Oct; 8(7):496-502. PubMed ID: 22340025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke.
    del Zoppo GJ; von Kummer R; Hamann GF
    J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):1-9. PubMed ID: 9667553
    [No Abstract]   [Full Text] [Related]  

  • 9. Early profiles of clinical evolution after intravenous thrombolysis in an unselected stroke population.
    Delgado MG; Michel P; Naves M; Maeder P; Reichhart M; Wintermark M; Bogousslavsky J
    J Neurol Neurosurg Psychiatry; 2010 Mar; 81(3):282-5. PubMed ID: 19850577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of hyperacute ischemic infarct with CT: key to improved clinical outcome after intravenous thrombolysis?
    Russell EJ
    Radiology; 1997 Nov; 205(2):315-8. PubMed ID: 9356608
    [No Abstract]   [Full Text] [Related]  

  • 11. Fatal ischemic brain oedema after tissue plasminogen activator.
    BMJ; 1989 Feb; 298(6670):382-3. PubMed ID: 2493944
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis.
    Dorado L; Millán M; de la Ossa NP; Guerrero C; Gomis M; López-Cancio E; Ricciardi AC; Dávalos A
    Eur J Neurol; 2010 Feb; 17(2):301-6. PubMed ID: 19912320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Tissue Plasminogen Activator Induces Neurological Side Effects Independent on Thrombolysis in Mechanical Animal Models of Focal Cerebral Infarction: A Systematic Review and Meta-Analysis.
    Dong MX; Hu QC; Shen P; Pan JX; Wei YD; Liu YY; Ren YF; Liang ZH; Wang HY; Zhao LB; Xie P
    PLoS One; 2016; 11(7):e0158848. PubMed ID: 27387385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombolytic therapy in ischemic infarct].
    Willig V; Steiner T; Hacke W
    Wien Klin Wochenschr; 1997 Oct; 109(20):795-803. PubMed ID: 9454430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteplase therapy in acute ischemic stroke: a Danish pilot study.OFF.
    Boysen G; Overgaard K; Sperling B; Pedersen H; Gam J; Ellemann K
    Z Kardiol; 1993; 82 Suppl 2():105-8. PubMed ID: 8328185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke.
    Heiss WD; Grond M; Thiel A; von Stockhausen HM; Rudolf J; Ghaemi M; Löttgen J; Stenzel C; Pawlik G
    J Cereb Blood Flow Metab; 1998 Dec; 18(12):1298-307. PubMed ID: 9850142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
    Asahi M; Asahi K; Wang X; Lo EH
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncontrast CT assessment of early cerebral ischaemia.
    Diotallevi P; Mazzetti Di Pietralata G; Montella F
    Radiol Med; 2002; 103(1-2):84-90. PubMed ID: 11859304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety Evaluation on Arterial Thrombolysis in Treating Acute Cerebral Infarction.
    Shen B; Liu Q; Gu Y; Wang Y; Zhang Z
    Cell Biochem Biophys; 2015 Nov; 73(2):297-304. PubMed ID: 27352315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.